apoio

Presidential symposium 1

LBA3_PR - Pembrolizumab versus placebo after complete resection of high-risk stage II melanoma: Efficacy and safety results from the KEYNOTE-716 double-blind phase III trial



17set
15h35 – 14h45
Online – Channel 4
17set
15h35 – 14h45
Online – Channel 1
17set
17h30 - 18h30
Online – Channel 7

Newsletter

Receba em primeira mão todas as notícias